Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
7.80
+0.07 (0.91%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Cartesian Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 118.64 | 125.14 | 212.61 | 76.91 | 106.44 | 114.06 |
Short-Term Investments | - | - | - | - | 28.16 | 14 |
Cash & Short-Term Investments | 118.64 | 125.14 | 212.61 | 76.91 | 134.6 | 128.06 |
Cash Growth | -34.25% | -41.14% | 176.44% | -42.86% | 5.11% | -7.66% |
Accounts Receivable | 0.26 | 1.12 | 0.87 | 5.87 | 6.6 | 9.91 |
Other Receivables | - | - | - | 2.98 | 3.16 | - |
Total Trade Receivables | 0.26 | 1.12 | 0.87 | 8.85 | 9.76 | 9.91 |
Other Current Assets | 3.14 | 3.02 | 3.14 | 4.97 | 3.78 | 6.47 |
Total Current Assets | 122.04 | 129.28 | 216.63 | 90.73 | 148.14 | 144.44 |
Net Property, Plant & Equipment | 17 | 17.79 | 15.45 | 12.18 | 14.41 | 11.97 |
Other Intangible Assets | 93.9 | 93.9 | 150.6 | 150.6 | - | - |
Goodwill | 48.16 | 48.16 | 48.16 | 48.16 | - | - |
Long-Term Investments | - | - | 2 | 2 | 2 | 2 |
Other Long-Term Assets | 7.29 | 7.29 | 2.19 | 1.38 | 1.34 | 1.47 |
Total Assets | 288.39 | 296.41 | 435.02 | 305.05 | 165.89 | 159.88 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.6 | 1.29 | 0.29 | 3.15 | 0.32 | 0.22 |
Accrued Expenses | 10.16 | 9.5 | 12.08 | 15.57 | 14.08 | 10.53 |
Short-Term Debt | - | - | - | - | 8.48 | 5.96 |
Current Portion of Leases | 4.19 | 4.15 | 2.85 | 2.17 | 1.61 | - |
Unearned Revenue | - | - | - | 2.31 | 0.59 | 53.88 |
Other Current Liabilities | - | - | 7.76 | 45.01 | - | - |
Total Current Liabilities | 15.95 | 14.94 | 22.98 | 68.21 | 25.08 | 72.25 |
Long-Term Debt | - | - | - | - | 17.79 | 19.67 |
Long-Term Leases | 7.67 | 8.53 | 11.13 | 8.79 | 10.06 | 8.6 |
Other Long-Term Liabilities | 412.9 | 399.19 | 407.72 | 367.68 | 19.14 | 36.84 |
Total Long-Term Liabilities | 420.56 | 407.71 | 418.85 | 376.47 | 46.98 | 65.11 |
Total Liabilities | 436.51 | 422.65 | 441.83 | 444.68 | 72.06 | 137.36 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0.01 |
Additional Paid-in Capital | 718.02 | 700.71 | 689.89 | 179.06 | 493.31 | 457.39 |
Accumulated Other Comprehensive Income | -4.58 | -4.58 | -4.62 | -4.6 | -4.56 | -4.57 |
Retained Earnings | -861.56 | -822.37 | -692.07 | -614.65 | -394.94 | -430.32 |
Total Common Shareholders' Equity | -148.12 | -126.24 | -6.8 | -440.18 | 93.83 | 22.52 |
Minority Interest | - | - | - | 300.55 | - | - |
Shareholders' Equity | 713.44 | 696.13 | 685.27 | -139.63 | 93.81 | 22.52 |
Total Liabilities & Equity | 288.39 | 296.41 | 435.02 | 305.05 | 165.89 | 159.88 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 11.86 | 12.68 | 13.98 | 10.96 | 37.93 | 34.23 |
Net Cash (Debt) | 106.79 | 112.46 | 198.63 | 65.96 | 96.68 | 93.82 |
Net Cash Growth | -35.81% | -43.38% | 201.15% | -31.78% | 3.04% | -10.00% |
Net Cash Per Share | 4.06 | 4.33 | 11.44 | 0.45 | 0.66 | 0.82 |
Book Value | -148.12 | -126.24 | -6.8 | -440.18 | 93.83 | 22.52 |
Book Value Per Share | -5.63 | -4.86 | -0.39 | -3.02 | 0.64 | 0.20 |
Tangible Book Value | -290.18 | -268.3 | -205.57 | -638.95 | 93.83 | 22.52 |
Tangible Book Value Per Share | -11.02 | -10.33 | -11.84 | -4.38 | 0.64 | 0.20 |